Wed, Sep 20, 2023
Oncology drugs constitute the largest proportion of the Serbian pharmaceutical market, where Venus Remedies has secured five marketing approvals, all in the oncology space.
More >
Tue, Nov 22, 2022
Shares of of the drug maker were trading 1.54 per cent up at Rs 417.9 apiece on BSE.
Tue, Sep 13, 2022
The list has been prepared after consultation with 350 experts. A total of 140 meetings took place before the list was finalised.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
